First-Year Economic and Quality of Life Effects of the RAINBOW Intervention to Treat Comorbid Obesity and Depression.

Jeremy D Goldhaber-FiebertLea PrinceLan XiaoNan LvLisa G RosasElizabeth M VendittiMegan A LewisMark B SnowdenJun Ma

Published in: Obesity (Silver Spring, Md.) (2020)

The RAINBOW intervention's economic value will depend on how its 1-year improvements in obesity and depression translate into long-term reduced morbidity, delayed mortality, or averted costs.

Keyphrases

insulin resistance
randomized controlled trial
metabolic syndrome
weight loss
high fat diet induced
depressive symptoms
type diabetes
weight gain
sleep quality
cardiovascular events
risk factors
skeletal muscle
body mass index
life cycle
coronary artery disease